To further investigate the role of YAP/TAZ activation as a downstream signal of EGFR in HNSCC, we implanted WT and LATS1/2 KO HCC827 cells into NOD-SCID mice, and treated them with erlotinib or vehicle control. The gene discussed is LATS1; the disease is head and neck squamous cell carcinoma.